Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach. - Wikidata - awgldk - TriplyDB

Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach.

Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach.

http://www.wikidata.org/entity/Q37205872

about

Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.High-dose-rate intraluminal brachytherapy prior to external radiochemotherapy in locally advanced esophageal cancer: preliminary results.

P2860

Q36304217-769777EE-6990-431B-B66D-65E283F72DCA Q37694549-B15348D2-0B8A-46CD-BD2A-A3AFBA0C8BDD

P2860

Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach.

http://www.wikidata.org/entity/Q37205872

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@en

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@nl

type

label

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@en

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@nl

prefLabel

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@en

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@nl

P1433

Q37205872-24E611F5-ADCB-47F3-BD6C-76A590904DB0

P1476

Q37205872-7F6A53CD-C08A-48BC-A719-A7AD9452866C

P2093

Q37205872-0AC208DB-0412-44A9-B47E-28D06A287BB7

Q37205872-3776B96B-C091-4EA9-B656-529E9B89FF10

Q37205872-40AFDA1D-FE5E-4BE7-B48B-5BBBC6482B59

Q37205872-42B112CD-27D4-4418-A746-941AB932ED61

Q37205872-48BBE934-8965-4F73-BAF7-1DDF74DA33F2

Q37205872-7E509985-EF6A-4577-9E85-63D8FB26CF6D

Q37205872-851EA68F-C312-4290-9D63-1DE167800050

Q37205872-A0BFF383-B966-466D-8328-4253EB062BDF

Q37205872-C46775B7-B0C8-4F00-90FB-2CD1967177A7

Q37205872-E1DAA790-EAAD-489B-83D4-D4CD531B9DA8

P2860

Q37205872-0F28F0CD-9568-4172-B269-86D7BD9EC6AC

Q37205872-1F946AD5-92BD-4878-8F82-2BF215F9079E

Q37205872-2872E899-3FB0-421B-9522-7C2F4A6CC709

Q37205872-34115638-2AE0-470C-9C81-0FC32136F622

Q37205872-465AD3FD-853C-44D1-A45A-DE615851D13C

Q37205872-4E05D2BB-BC17-4FBB-858D-2914C19D21F5

Q37205872-60BE3B5C-C005-4280-8107-8B571376CB65

Q37205872-7F234EBB-319C-40ED-BDD5-F8675346F103

Q37205872-971223DE-27C3-4BD1-8A4C-A36ED76ED66F

Q37205872-AA71DAA6-F32D-44B2-89D3-9F3012FEFB1D

P304

Q37205872-4BF87B2D-788E-4CD8-BE68-94AC8E3F03C4

P31

Q37205872-B46879DA-A583-4DB5-BEC9-8BE528D835AD

P356

Q37205872-C9DAAB68-AD8C-46CC-926A-D6AE5EEF8F9B

P407

Q37205872-C5292BA1-8958-4775-89C8-9D737565ABE3

P433

Q37205872-66494508-53E2-4A57-89BD-79BD297CB5F5

P478

Q37205872-C12211C3-5E4E-4F92-9651-A478C0B521E3

P577

Q37205872-38B4A796-65FE-435D-9FBE-B295A54B0C25

P698

Q37205872-0DE4E441-9646-4EBC-9741-50C3D00B0E4A

P921

Q37205872-6449A5C0-F430-4EBC-A997-27AD591AE441

P932

Q37205872-132DB1DA-605A-4380-A3AE-AD006F17C792

P356

MD.0000000000003151

P1433

P1476

Prognostic Significance of 2-D ...... ery: A Nonparametric Approach.

@en

P2093

Andrea Ripoli

http://www.w3.org/2001/XMLSchema#string

Assuero Giorgetti

http://www.w3.org/2001/XMLSchema#string

Biagio Solito

http://www.w3.org/2001/XMLSchema#string

Dario Genovesi

http://www.w3.org/2001/XMLSchema#string

Giovanni Pallabazzer

http://www.w3.org/2001/XMLSchema#string

Laura Pieraccini

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Fabrini

http://www.w3.org/2001/XMLSchema#string

Monica Lencioni

http://www.w3.org/2001/XMLSchema#string

Paolo Marzullo

http://www.w3.org/2001/XMLSchema#string

Simone D'Imporzano

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review.

Neoadjuvant therapy for esophageal cancer

Clinical tools to predict outcomes in patients with esophageal cancer treated with definitive chemoradiation: are we there yet?

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.

Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.

The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).

TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer.

P304

e3151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000003151

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27043676

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4998537

http://www.w3.org/2001/XMLSchema#string